Raia Drogasil S.A. RADLY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 254.06M | 236.02M | 233.84M | 237.32M | 214.37M |
| Total Depreciation and Amortization | 366.58M | 355.42M | 336.03M | 306.68M | 301.42M |
| Total Amortization of Deferred Charges | 44.41M | 40.11M | 37.51M | 43.15M | 40.68M |
| Total Other Non-Cash Items | 47.39M | 32.46M | 8.76M | 20.71M | 5.46M |
| Change in Net Operating Assets | -140.04M | -170.13M | -179.37M | -62.69M | -59.35M |
| Cash from Operations | 572.40M | 493.88M | 436.77M | 545.17M | 502.57M |
| Capital Expenditure | -262.79M | -255.67M | -252.52M | -246.51M | -243.66M |
| Sale of Property, Plant, and Equipment | 225.30K | 119.80K | 119.80K | 105.20K | 0.00 |
| Cash Acquisitions | 28.61M | -- | -- | 0.00 | -21.25M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.68M | -5.80M | 231.10K | -17.81M | -13.45M |
| Cash from Investing | -222.28M | -261.35M | -252.17M | -264.21M | -278.36M |
| Total Debt Issued | 600.00M | 1.10B | 1.19B | 628.87M | 629.29M |
| Total Debt Repaid | -1.82B | -1.66B | -1.58B | -1.58B | -1.26B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -11.17M | -10.94M | -5.48M | -73.29M | -73.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -112.62M | -118.26M | -118.19M | -94.78M | -94.97M |
| Other Financing Activities | -- | -- | -- | -- | 117.82M |
| Cash from Financing | -347.33M | -226.84M | -187.16M | -276.98M | -196.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.78M | 5.68M | -2.56M | 3.97M | 27.99M |